Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotropin for Oxaliplatin-induced Neurotoxicity in Colorectal Cancer
NCT07320950Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2022
- Primary completion
- Aug 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of vaccinia virus-inoculated rabbit skin extract in Oxaliplatin-induced peripheral neurotoxicity (OIPN), sponsored by Sun Yat-sen University. Started Apr 2022; status: completed.
02
Drugs
vaccinia virus-inoculated rabbit skin extract
03
Conditions
Oxaliplatin-induced peripheral neurotoxicity (OIPN)
Beyond the preview
Go deeper on NCT07320950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320950.